5 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Peter Salzmann
REVOLUTION Medicines
5 followers
Summit Therapeutics
5 followers
Dyne Therapeutics
3 followers
Gamida Cell
2 followers
Entrada Therapeutics
1 follower
Century Therapeutics
1 follower
Ardelyx
3 followers
Akoya Biosciences
2 followers
Biolinq
1 follower
Regulus Therapeutics
1 follower
Thermo Fisher Scientific
180 followers
Explore companies